Prices delayed by at least 15 minutes | Print


Charles River Laboratories International (CRL)

-
Sell: $208.08|Buy: $261.9|Change: 0.70 (-0.29%)

Open 

$239.28


Previous close 

$240.13


Trade high 

$244.56


Volume 

705,117


Year high 

$275.00


Year low 

$161.65


Dividend yield 

-


Market capitalisation 

$12.33 bn


P/E ratio 

26.04


ISIN 

US1598641074


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 24/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Charles River Laboratories International- 0.29
More...

Company profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.